GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...

As per Indian Market Research Bureau, 73% of urban rich Indians are protein deficient. Horlicks Protein Plus, India’s first protein supplement with triple blend formula, is a relatively new entrant ...